Create Free Account

By creating account you will get access to hot stocks & personalised emails

Siemens Healthineers AG

Healthcare US SEMHF

55.825USD
-(-%)

Last update at 2024-12-18T20:00:00Z

Day Range

56.0056.00
LowHigh

52 Week Range

46.9763.15
LowHigh

Fundamentals

  • Previous Close 55.83
  • Market Cap65351.82M
  • Volume1531
  • P/E Ratio39.57
  • Dividend Yield1.74%
  • EBITDA3211.00M
  • Revenue TTM21680.00M
  • Revenue Per Share TTM19.37
  • Gross Profit TTM 8137.00M
  • Diluted EPS TTM1.48

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Income before tax 1928.00M 2800.00M 2404.00M 1954.00M 2193.00M
Minority interest -16.00000M -17.00000M -18.00000M 13.00M 13.00M
Net income 1509.00M 2038.00M 1727.00M 1411.00M 1567.00M
Selling general administrative 3607.00M 3408.00M 2817.00M 2279.00M 2214.00M
Selling and marketing expenses - - - - -
Gross profit 7709.00M 8137.00M 6952.00M 5580.00M 5796.00M
Reconciled depreciation 1557.00M 1343.00M 1039.00M 815.00M 620.00M
Ebit 2224.00M 2918.00M 2476.00M 1996.00M 2316.00M
Ebitda 3781.00M 4261.00M 3515.00M 2811.00M 2936.00M
Depreciation and amortization 1557.00M 1343.00M 1039.00M 815.00M 620.00M
Non operating income net other - - - - -
Operating income 2224.00M 2918.00M 2476.00M 1996.00M 2316.00M
Other operating expenses 19547.00M 18790.00M 15440.00M 12516.00M 12222.00M
Interest expense 296.00M 118.00M 83.00M 76.00M 123.00M
Tax provision 403.00M 746.00M 658.00M 532.00M 607.00M
Interest income 85.00M 48.00M 33.00M 53.00M 38.00M
Net interest income -207.00000M -127.00000M -170.00000M -28.00000M -107.00000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 403.00M 746.00M 658.00M 532.00M 607.00M
Total revenue 21680.00M 21714.00M 17997.00M 14460.00M 14518.00M
Total operating expenses 5576.00M 5213.00M 4395.00M 3636.00M 3500.00M
Cost of revenue 13971.00M 13577.00M 11045.00M 8880.00M 8722.00M
Total other income expense net -296.00000M -118.00000M -72.00000M -42.00000M -123.00000M
Discontinued operations - - - - -
Net income from continuing ops 1525.00M 2054.00M 1746.00M 1422.00M 1586.00M
Net income applicable to common shares - 2038.00M 1727.00M 1411.00M 1567.00M
Preferred stock and other adjustments - - - - -
Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Total assets 46684.00M 49056.00M 42162.00M 25094.00M 21429.00M
Intangible assets 7726.00M 8712.00M 8211.00M 1912.00M 1576.00M
Earning assets - - - - -
Other current assets 25.00M 28.00M 25.00M 27.00M 12.00M
Total liab 28551.00M 29204.00M 25823.00M 12583.00M 11647.00M
Total stockholder equity 18081.00M 19836.00M 16321.00M 12498.00M 9769.00M
Deferred long term liab - - - - -
Other current liab 168.00M 178.00M 213.00M 136.00M 148.00M
Common stock 1128.00M 1128.00M 1128.00M 1075.00M 1000.00M
Capital stock 1128.00M 1128.00M 1128.00M 1075.00M 1000.00M
Retained earnings 1381.00M 894.00M -300.00000M -1276.00000M -1859.00000M
Other liab - 3369.00M 3594.00M 1998.00M 1951.00M
Good will 18118.00M 19061.00M 17512.00M 9038.00M 8590.00M
Other assets - 4070.00M 2141.00M -1.00000M 1429.00M
Cash 1642.00M 1436.00M 1322.00M 656.00M 920.00M
Cash and equivalents - - - - -
Total current liabilities 13440.00M 12024.00M 10065.00M 7289.00M 5605.00M
Current deferred revenue 10872.00M 9282.00M 7682.00M 5630.00M 3974.00M
Net debt -1009.00000M -704.00000M -569.00000M -175.00000M -779.00000M
Short term debt 197.00M 249.00M 249.00M 167.00M 80.00M
Short long term debt 31.00M 67.00M 73.00M 60.00M 70.00M
Short long term debt total 633.00M 732.00M 753.00M 481.00M 141.00M
Other stockholder equity 15572.00M 17814.00M 15493.00M 12699.00M 10628.00M
Property plant equipment - 3632.00M 3295.00M 2510.00M 1944.00M
Total current assets 14136.00M 13379.00M 10824.00M 10268.00M 7779.00M
Long term investments - - - - 132.00M
Net tangible assets - -7937.00000M -9493.00000M 1548.00M -397.00000M
Short term investments 124.00M 162.00M 79.00M 31.00M 28.00M
Net receivables 8084.00M 7781.00M 6244.00M 7280.00M 4773.00M
Long term debt 10.00M 15.00M 19.00M 49.00M 39.00M
Inventory 4261.00M 3972.00M 3154.00M 2274.00M 2046.00M
Accounts payable 2203.00M 2315.00M 1921.00M 1356.00M 1403.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1924.00M 2925.00M 1244.00M 580.00M 600.00M
Deferred long term asset charges - - - - -
Non current assets total 32548.00M 35677.00M 31338.00M 14827.00M 13650.00M
Capital lease obligations 592.00M 650.00M 590.00M 372.00M 32.00M
Long term debt total - - - - -
Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Investments -1069.00000M 15.00M 15.00M -1.00000M -1.00000M
Change to liabilities - 791.00M 643.00M 128.00M 268.00M
Total cashflows from investing activities - -868.00000M -14140.00000M -1912.00000M -647.00000M
Net borrowings - -169.00000M -155.00000M -101.00000M 52.00M
Total cash from financing activities -690.00000M -1644.00000M 11839.00M -249.00000M -603.00000M
Change to operating activities - -663.00000M 453.00M -39.00000M -140.00000M
Net income 1525.00M 2054.00M 1746.00M 1423.00M 1586.00M
Change in cash 206.00M 114.00M 666.00M -264.00000M 401.00M
Begin period cash flow 1436.00M 1322.00M 656.00M 920.00M 519.00M
End period cash flow 1642.00M 1436.00M 1322.00M 656.00M 920.00M
Total cash from operating activities 2119.00M 2504.00M 2933.00M 1928.00M 1617.00M
Issuance of capital stock - 1.00M 2311.00M 2709.00M -
Depreciation 1557.00M 1343.00M 1039.00M 815.00M 620.00M
Other cashflows from investing activities - - 1.00M 1.00M 1.00M
Dividends paid -1066.00000M -955.00000M -856.00000M -798.00000M 699.00M
Change to inventory -453.00000M -481.00000M -22.00000M -332.00000M -124.00000M
Change to account receivables - -478.00000M -720.00000M 55.00M -485.00000M
Sale purchase of stock -421.00000M -309.00000M -255.00000M -67.00000M -51.00000M
Other cashflows from financing activities 1354.00M -232.00000M 10777.00M -1853.00000M 147.00M
Change to netincome - -46.00000M -187.00000M -110.00000M -89.00000M
Capital expenditures 838.00M 852.00M 674.00M 557.00M 579.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -602.00000M -831.00000M 354.00M -188.00000M -481.00000M
Stock based compensation - - - - -
Other non cash items -361.00000M -62.00000M -206.00000M -122.00000M -108.00000M
Free cash flow 1281.00M 1652.00M 2259.00M 1371.00M 1038.00M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
SEMHF
Siemens Healthineers AG		 - -% 55.83 39.57 21.32 3.01 3.29 2.95 16.92
ABT
Abbott Laboratories		 1.29 1.15% 113.22 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -0.41 0.11% 358.76 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 0.41 0.51% 80.44 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 1.08 1.23% 89.11 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Siemens Healthineers AG

Henkestrasse 127, Erlangen, Germany, 91052

Key Executives

Name Title Year Born
Dr. Bernhard Montag Pres, CEO & Chairman of Management Board 1969
Dr. Jochen Schmitz CFO & Member of Management Board 1966
Ms. Darleen Caron Chief HR Officer, Labor Director & Member of Management Board 1964
Ms. Elisabeth Staudinger Member of Management Board 1970
Mr. Marc Koebernick Head of Investor Relations NA
Dr. Michel Therin D.V.M., Ph.D. Pres of Advanced Therapies 1961
Christian Klaussner Exec. VP of Fin. NA
Andre Hartung Head of Imaging NA
Mr. Christopher A. Toth Head of Varian 1979
Carsten Bertram Head of Advanced Therapies NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.